Previous Close | 7.14 |
Open | 7.34 |
Bid | 7.30 x 0 |
Ask | 7.33 x 0 |
Day's Range | 7.33 - 7.35 |
52 Week Range | 7.00 - 15.43 |
Volume | |
Avg. Volume | 1,183 |
Market Cap | 200.58M |
Beta (5Y Monthly) | 0.26 |
PE Ratio (TTM) | 81.44 |
EPS (TTM) | 0.09 |
Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in upcoming investor conferences. The management team will also host one-on-one investor meetings at the conferences. Conference Details: Event: H.C. Wainwright Global Investment ConferenceDate: September 11, 2024Time: Company Presentation at 12:00 p.m. – 12:30 p.m. ETLocat
One thing we could say about the analysts on Fennec Pharmaceuticals Inc. ( NASDAQ:FENC ) - they aren't optimistic...
Fennec Pharmaceuticals ( NASDAQ:FENC ) Second Quarter 2024 Results Key Financial Results Revenue: US$7.26m (up 118...